Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Subjects With Type 2 Diabetes Mellitus.”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01215903
What this trial is testing

Fish Gelatin Supplement and Omega-3 Supplement in Obese or Overweight Subjects With Insulin Resistance

Who this might be right for
Insulin ResistanceType 2 Diabetes
Laval University 21
Large-scale testing (Phase 3)Study completedNCT01388361
What this trial is testing

Comparison of the Efficacy and Safety of Two Intensification Strategies in Subjects With Type 2 Diabetes Inadequately Controlled on Basal Insulin and Metformin

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 413
Not applicableStudy completedNCT00700765
What this trial is testing

Observational Study to Evaluate Safety of Levemir® in Type 1 and Type 2 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2
Novo Nordisk A/S 1,531
Large-scale testing (Phase 3)Study completedNCT01135992
What this trial is testing

Switching From Insulin Glargine to Insulin Degludec in Subjects With Type 2 Diabetes Mellitus (BEGIN™)

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 143
Post-approval studies (Phase 4)Study completedNCT02372630
What this trial is testing

The Effect of LINAGLIPTIN on Inflammation, Oxidative Stress and Insulin Resistance in Obese Type 2 Diabetes Subjects

Who this might be right for
Type 2 Diabetes
University at Buffalo 40
Early research (Phase 1)Ended earlyNCT01492465
What this trial is testing

Single Ascending Dose Trial in Patients With Type 2 Diabetes

Who this might be right for
Diabetes Mellitus
Amgen 47
Large-scale testing (Phase 3)Looking for participantsNCT07193459
What this trial is testing

Study to Evaluate HDM1002 Tablets in Adults With Type 2 Diabetes Mellitus

Who this might be right for
Type 2 Diabetes
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. 360
Testing effectiveness (Phase 2)Study completedNCT01263470
What this trial is testing

Efficacy and Safety of Alogliptin in Participants With Type 2 Diabetes in Japan

Who this might be right for
Diabetes Mellitus, Type 2
Takeda 480
Not applicableNot Yet RecruitingNCT07377097
What this trial is testing

Effects of Sweetener Consumption on Risk Factors for Heart Disease in Prediabetic Subjects

Who this might be right for
Prediabetic StateMetabolic SyndromeInsulin Resistance+8 more
Charite University, Berlin, Germany 80
Large-scale testing (Phase 3)Study completedNCT05606913
What this trial is testing

IBI362 in Participants With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes
Innovent Biologics (Suzhou) Co. Ltd. 731
Testing effectiveness (Phase 2)Study completedNCT00495469
What this trial is testing

Dose-Ranging Study In Subjects With Type 2 Diabetes Mellitus Who Are Treatment-Naive

Who this might be right for
Diabetes Mellitus, Type 2
GlaxoSmithKline 250
Large-scale testing (Phase 3)UnknownNCT06339086
What this trial is testing

Efficacy and Safety of Semaglutide Injection in Subjects With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes Mellitus
Chengdu Brilliant Pharmaceutical Co., Ltd. 478
Not applicableStudy completedNCT02866539
What this trial is testing

Effect of Polyherbal Compound for Control of Blood Sugar in Impaired Glucose Tolerance and Diabetes

Who this might be right for
Diabetes Mellitus
Composite Interceptive Med Science 122
Not applicableStudy completedNCT01947595
What this trial is testing

Individualized Lifestyle Intervention in Subjects With Prediabetes

Who this might be right for
Diabetes Mellitus Type 2
University Hospital Tuebingen 1,145
Large-scale testing (Phase 3)Study completedNCT01680341
What this trial is testing

Comparison of the Efficacy and Safety of Two Different Dose Adjustment Regimens for Insulin Degludec/Insulin Aspart in Subjects With Type 2 Diabetes Mellitus Previously Treated With Insulin Glargine

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 272
Not applicableStudy completedNCT00570154
What this trial is testing

Relation of White Blood Cell Function to Diabetes

Who this might be right for
Diabetes
National Heart, Lung, and Blood Institute (NHLBI) 100
Large-scale testing (Phase 3)Study completedNCT01570751
What this trial is testing

A Trial Comparing the Efficacy, Patient-reported Outcomes and Safety of Insulin Degludec 200 U/mL vs Insulin Glargine in Subjects With Type 2 Diabetes Mellitus Requiring High-dose Insulin

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 145
Large-scale testing (Phase 3)Study completedNCT04974528
What this trial is testing

Afrezza® INHALE-1 Study in Pediatrics

Who this might be right for
Diabetes Mellitus, Type 1Diabetes Mellitus, Type 2
Mannkind Corporation 319
Large-scale testing (Phase 3)Study completedNCT01814137
What this trial is testing

A Randomised Trial Comparing Efficacy and Safety After Intensification With Either Insulin Aspart Once Daily as add-on or Changing to Basal Bolus Treatment With Insulin Degludec and Insulin Aspart in Subjects With Type 2 Diabetes Previously Treated With Insulin Degludec/Insulin Aspart Twice Daily

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 40
Large-scale testing (Phase 3)Study completedNCT00383877
What this trial is testing

Effect of Insulin Detemir on Blood Glucose Control in Subjects With Type 2 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 263
Next Page